Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07444047

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

Sponsor: Oslo University Hospital

View on ClinicalTrials.gov

Summary

This study investigates whether an advanced MRI technique called Quantitative Susceptibility Mapping (QSM) can improve the differentiation of white matter lesions in people aged 50-70 years with multiple sclerosis (MS). In older individuals with MS, white matter changes seen on MRI may be related to MS or to other types of white matter changes, most commonly age-related changes or chronic small vessel disease. These conditions can appear similar on conventional MRI scans, making interpretation challenging. Participants will undergo routine clinical MRI, including a short additional QSM sequence, as well as brief cognitive and physical assessments. A comparison group with cerebral small vessel disease will also be included. The goal of the study is to determine whether QSM can provide more precise lesion characterization and support more accurate clinical interpretation of MRI findings in older patients with MS.

Official title: Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis

Key Details

Gender

All

Age Range

50 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2026-03

Completion Date

2031-12-31

Last Updated

2026-03-02

Healthy Volunteers

No

Locations (1)

Oslo University Hospital

Oslo, Oslo County, Norway